Chocolate ‘Offenders’ Teach Science a Sweet Lesson
Some ?chocoholics? who just couldn?t give up their favorite treat to comply with a study to test blood stickiness have inadvertently done their fellow chocolate lovers – and science – a big favor.
Diet
Hemodialysis :: Obesity an advantage in MHD patients
Despite significant improvements in dialysis treatments, currently over 20 percent of the 350,000 maintenance hemodialysis patients in the United States die each year. A study published in Hemodialysis International finds that this high mortality rate may be attributed to malnutrition.
Fatigue in women is reduced in stress-related cortisol study
A study of healthy women has harvested results involving fatigue and vigor that eventually may help researchers fine tune efforts to treat a multitude of illnesses and syndromes linked to low levels of the stress hormone cortisol.
Dementia :: Higher level of certain fatty acid associated with lower dementia risk
Individuals who have higher levels of a fatty acid known as docosahexaenoic acid in their blood may have a significantly lower risk of developing dementia and Alzheimer’s disease, according to a report in the November issue of Archives of Neurology, one of the JAMA/Archives journals.
Depression :: Depression, not antidepressants, increases heart failure risk
People who are depressed have an increased risk of dying from heart failure, and a new study by Duke University Medical Center researchers may help explain why.
Heart Disease :: Children with heart disease risk factors should get preventive treatment
Children with risk factors such as high blood pressure, obesity, diabetes and high cholesterol levels already show signs of fatty build-up in their arteries that could lead to heart attack in adulthood, researchers reported at the American Heart Association’s Scientific Sessions 2006.
Health :: Abbott to Expand Presence in Lipid Management Market with Acquisition of Kos Pharmaceuticals
Abbott and Kos Pharmaceuticals, Inc. today announced a definitive agreement for Abbott to acquire Kos for $78 per share in cash, for a total transaction value of $3.7 billion, net of cash currently held by Kos. Based in Cranbury, N.J., Kos is a specialty pharmaceutical company that develops and markets proprietary medications for the treatment of chronic cardiovascular, metabolic and respiratory diseases. The company has a growing presence in the $20 billion lipid management market.
Low Carb Diet :: Low carb diets and risk of heart disease – new research
Low-carbohydrate diets have been advocated for weight loss and to prevent obesity, but the long-term safety of these diets has not been determined. A study was conducted by Dr. Hu at the Department of Nutrition, Harvard School of Public Health, Boston.
Health :: Colorado Company to Sell Medical Food Products Based on Wake Forest Discovery
A Colorado-based company is launching a line of ‘medical- food’ products for the dietary management of asthma, eczema and other allergic conditions based on discoveries by Floyd H. ‘Ski’ Chilton, Ph.D., of Wake Forest University Health Sciences (WFUHS).
Diabetes :: Indian probiotic yoghurt Dahi linked to slow diabetes development
A daily supplement of the Indian probiotic yoghurt, dahi, may lower the risk of diabetes, says a new study from the home of the dairy product.